| Bibliographic Citation
| - Lortholary Olivier, Chandesris Marie, Livideanu Cristina, Paul Carle, Guillet Gérard, Jassem Ewa, Niedoszytko Marek, Barete Stéphane, Verstovsek Srdan, Grattan Clive, Damaj Gandhi, Canioni Danielle, Fraitag Sylvie, Lhermitte Ludovic, Lavialle Sophie, Frenzel Laurent, Afrin Lawrence, Hanssens Katia, Agopian Julie, Gaillard Raphaël, Kinet Jean-Pierre, Auclair Christian, Mansfield Colin, Moussy Alain, Dubreuil Patrice. Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. The Lancet, Elsevier, 2017, 389 (10069), pp.612-620. ⟨10.1016/S0140-6736(16)31403-9⟩
- Lortholary Olivier, Chandesris Marie, Livideanu Cristina, Paul Carle F, Guillet Gérard, Jassem Ewa, Niedoszytko Marek, Barete Stéphane, Verstovsek Srdan, Grattan Clive, Damaj Gandhi, Canioni Danielle, Fraitag Sylvie, Lhermitte Ludovic, Lavialle Sophie, Frenzel Laurent, Afrin Lawrence, Hanssens Katia, Agopian Julie, Gaillard Raphaël, Kinet Jean-Pierre, Auclair Christian, Mansfield Colin, Moussy Alain, Dubreuil Patrice. Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. The Lancet, Elsevier, 2017, 389 (10069), pp.612-620. ⟨10.1016/S0140-6736(16)31403-9⟩
- Lortholary Olivier, Chandesris Marie, Livideanu Cristina, Paul Carle F, Guillet Gérard, Jassem Ewa, Niedoszytko Marek, Barete Stéphane, Verstovsek Srdan, Grattan Clive, Damaj Gandhi, Canioni Danielle, Fraitag Sylvie, Lhermitte Ludovic, Lavialle Sophie, Frenzel Laurent, Afrin Lawrence, Hanssens Katia, Agopian Julie, Gaillard Raphaël, Kinet Jean-Pierre, Auclair Christian, Mansfield Colin, Moussy Alain, Dubreuil Patrice. Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. The Lancet, 2017, 389 (10069), pp.612-620. ⟨10.1016/S0140-6736(16)31403-9⟩
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
